NeuroSense Therapeutics Ltd. (NRSN) vs Exicure, Inc. (XCUR)
A side-by-side comparison of NeuroSense Therapeutics Ltd. and Exicure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NRSN
NeuroSense Therapeutics Ltd.
$4.01HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
XCUR
Exicure, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
Total return — NRSN vs XCUR
growth of $100 · dividends reinvested · last 5yNRSN -95.0% (-45.1%/yr)XCUR -98.5% (-56.5%/yr)NRSN compounded faster over this window
NRSN XCUR
NRSN vs XCUR: by the numbers
- •NRSN is the larger company ($7M vs $7M market cap).
Metrics side by side
Valuation
| Metric | NRSN | XCUR |
|---|---|---|
| P/B ratio | N/A | 7.11 |
Profitability
| Metric | NRSN | XCUR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -847.90% |
| ROIC | N/A | -101.07% |
Growth (annualized)
| Metric | NRSN | XCUR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -64.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.